Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bacillus B8W22. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109762768B details a novel Bacillus B8W22 strain for producing high-purity pharmaceutical intermediates with superior stereoselectivity and reduced environmental impact.